Boning Up On Biotech Value

John McCamant, editor of Medical Technology Stock Letter, recommends buying shares of NPS Pharmaceuticals, the Salt Lake City-based biopharmaceutical company specializing in discovering, developing and commercializing small-molecule drugs and recombinant proteins aimed at treatment of bone and mineral disorders, as well as gastrointestinal and central nervous system ailments.

Back to news